Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1989 3
1992 2
1993 2
1995 4
1997 1
1998 1
1999 1
2001 2
2003 2
2004 2
2005 1
2006 2
2007 1
2008 1
2009 3
2010 1
2011 1
2012 5
2013 4
2014 9
2015 9
2016 9
2017 6
2018 7
2019 7
2020 12
2021 15
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

105 results
Results by year
Filters applied: . Clear all
Page 1
Fabry Disease: The Current Treatment Landscape.
Lenders M, Brand E. Lenders M, et al. Drugs. 2021 Apr;81(6):635-645. doi: 10.1007/s40265-021-01486-1. Epub 2021 Mar 15. Drugs. 2021. PMID: 33721270 Free PMC article. Review.
Treatment of fabry disease with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS).
Lenders M, Nordbeck P, Kurschat C, Eveslage M, Karabul N, Kaufeld J, Hennermann JB, Patten M, Cybulla M, Müntze J, Üçeyler N, Liu D, Das AM, Sommer C, Pogoda C, Reiermann S, Duning T, Gaedeke J, von Cossel K, Blaschke D, Brand SM, Alexander Mann W, Kampmann C, Muschol N, Canaan-Kühl S, Brand E. Lenders M, et al. Eur Heart J Cardiovasc Pharmacother. 2021 Mar 16:pvab025. doi: 10.1093/ehjcvp/pvab025. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 33725118
Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS).
Lenders M, Nordbeck P, Kurschat C, Karabul N, Kaufeld J, Hennermann JB, Patten M, Cybulla M, Müntze J, Üçeyler N, Liu D, Das AM, Sommer C, Pogoda C, Reiermann S, Duning T, Gaedeke J, Stumpfe K, Blaschke D, Brand SM, Mann WA, Kampmann C, Muschol N, Canaan-Kühl S, Brand E. Lenders M, et al. Clin Pharmacol Ther. 2020 Aug;108(2):326-337. doi: 10.1002/cpt.1832. Epub 2020 Apr 27. Clin Pharmacol Ther. 2020. PMID: 32198894
Dr. Jan Holsheimer 1941-2021.
Lenders MWPM, Kho KH, de Vos CC, Elands A. Lenders MWPM, et al. Neuromodulation. 2021 Jun;24(4):609. doi: 10.1111/ner.13416. Neuromodulation. 2021. PMID: 34160874 No abstract available.
Precision medicine in Fabry disease.
Lenders M, Brand E. Lenders M, et al. Nephrol Dial Transplant. 2021 Jun 22;36(Suppl 2):14-23. doi: 10.1093/ndt/gfab038. Nephrol Dial Transplant. 2021. PMID: 34153986 Review.
Treatment switch in Fabry disease- a matter of dose?
Lenders M, Nordbeck P, Canaan-Kühl S, Kreul L, Duning T, Lorenz L, Pogoda C, Brand SM, Wanner C, Brand E. Lenders M, et al. J Med Genet. 2021 May;58(5):342-350. doi: 10.1136/jmedgenet-2020-106874. Epub 2020 Jun 10. J Med Genet. 2021. PMID: 32522756
Circulating microRNAs in Fabry Disease.
Xiao K, Lu D, Hoepfner J, Santer L, Gupta S, Pfanne A, Thum S, Lenders M, Brand E, Nordbeck P, Thum T. Xiao K, et al. Among authors: lenders m. Sci Rep. 2019 Oct 24;9(1):15277. doi: 10.1038/s41598-019-51805-6. Sci Rep. 2019. PMID: 31649303 Free PMC article.
In Vitro and In Vivo Amenability to Migalastat in Fabry Disease.
Lenders M, Stappers F, Brand E. Lenders M, et al. Mol Ther Methods Clin Dev. 2020 Aug 20;19:24-34. doi: 10.1016/j.omtm.2020.08.012. eCollection 2020 Dec 11. Mol Ther Methods Clin Dev. 2020. PMID: 32995357 Free PMC article. Review.
105 results